Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP versus PRF split-face trial in refractory melasma
IRCT20240822062839N3Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2025
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of platelet-rich plasma and platelet rich fibrin in melasma (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: modified Melasma Area and Severity Index (mMASI) score. Started Sep 2025; status: completed.
02
Drugs
platelet-rich plasmaplatelet rich fibrin
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20240822062839N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240822062839N3.